JP2016503403A5 - - Google Patents

Download PDF

Info

Publication number
JP2016503403A5
JP2016503403A5 JP2015540765A JP2015540765A JP2016503403A5 JP 2016503403 A5 JP2016503403 A5 JP 2016503403A5 JP 2015540765 A JP2015540765 A JP 2015540765A JP 2015540765 A JP2015540765 A JP 2015540765A JP 2016503403 A5 JP2016503403 A5 JP 2016503403A5
Authority
JP
Japan
Prior art keywords
alkyl
acceptable salt
pharmaceutically acceptable
compound
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015540765A
Other languages
English (en)
Japanese (ja)
Other versions
JP6372666B2 (ja
JP2016503403A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/067674 external-priority patent/WO2014070979A1/en
Publication of JP2016503403A publication Critical patent/JP2016503403A/ja
Publication of JP2016503403A5 publication Critical patent/JP2016503403A5/ja
Application granted granted Critical
Publication of JP6372666B2 publication Critical patent/JP6372666B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015540765A 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤 Active JP6372666B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261722152P 2012-11-03 2012-11-03
US61/722,152 2012-11-03
PCT/US2013/067674 WO2014070979A1 (en) 2012-11-03 2013-10-31 Inhibitors of cytomegalovirus

Publications (3)

Publication Number Publication Date
JP2016503403A JP2016503403A (ja) 2016-02-04
JP2016503403A5 true JP2016503403A5 (enExample) 2016-12-15
JP6372666B2 JP6372666B2 (ja) 2018-08-15

Family

ID=49620281

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015540765A Active JP6372666B2 (ja) 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤

Country Status (4)

Country Link
US (1) US9334249B2 (enExample)
EP (1) EP2914592B1 (enExample)
JP (1) JP6372666B2 (enExample)
WO (1) WO2014070979A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT202400142T1 (it) 2014-01-13 2024-05-14 Aurigene Oncology Ltd Enantiomeri (r) e (s) di n-(5-(3-idrossipirrolidin-1-il)-2-morfolinoossazolo[4,5-b]piridin-6-il)-2-(2-metilpiridin-4-il)ossazolo-carbossammide in qualità di inibitori di irak4 per il trattamento di un cancro
CN120267671A (zh) 2017-03-31 2025-07-08 奥锐金肿瘤有限公司 用于治疗血液病的化合物和组合物
MX2020003666A (es) 2017-10-31 2020-08-03 Curis Inc Compuestos y composiciones para el tratamiento de trastornos hematologicos.
AU2019339777B2 (en) 2018-09-12 2022-09-01 Novartis Ag Antiviral pyridopyrazinedione compounds
US11667613B2 (en) 2019-09-26 2023-06-06 Novartis Ag Antiviral pyrazolopyridinone compounds
CN111763201A (zh) * 2020-03-03 2020-10-13 中国药科大学 苯并噻唑类化合物及医药用途
CN113831301B (zh) * 2020-06-08 2023-06-06 沈阳药科大学 苯并噻唑类衍生物及其用途
CA3187651A1 (en) * 2020-07-31 2022-02-03 Eric Sorscher Cystic fibrosis transmembrane conductance regulator (cftr) modulators, pharmaceutical compositions, and uses thereof
US12178821B2 (en) 2021-04-08 2024-12-31 Curis, Inc. Combination therapies for the treatment of cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1348446A (zh) 1998-12-09 2002-05-08 美国家庭用品有限公司 含苯二胺基团的含杂环羧酰胺的疱疹病毒硫脲抑制剂
AU2353900A (en) 1998-12-09 2000-06-26 Wyeth Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
CZ20011957A3 (cs) 1998-12-09 2001-10-17 American Home Products Corporation Thiomočoviny jako inhibitory herpes virů
US6166028A (en) 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
DE50204780D1 (de) 2001-04-19 2005-12-08 Bayer Healthcare Ag Arylsulfonamide als antivirale mittel
EP1529046A1 (en) 2002-08-08 2005-05-11 Boehringer Ingelheim Pharmaceuticals Inc. Substituted benzimidazole compounds
WO2007059157A1 (en) 2005-11-14 2007-05-24 Genentech, Inc. Bisamide inhibitors of hedgehog signaling
JP5296688B2 (ja) * 2006-09-11 2013-09-25 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 殺虫化合物
US20090069288A1 (en) * 2007-07-16 2009-03-12 Breinlinger Eric C Novel therapeutic compounds
WO2010029300A1 (en) 2008-09-12 2010-03-18 Biolipox Ab Bis aromatic compounds for use in the treatment of inflammation
EP2177521A1 (en) 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
TW201103904A (en) * 2009-06-11 2011-02-01 Hoffmann La Roche Janus kinase inhibitor compounds and methods

Similar Documents

Publication Publication Date Title
JP2015536947A5 (enExample)
JP2016505614A5 (enExample)
JP2015500843A5 (enExample)
JP2012144574A5 (enExample)
JP2015512931A5 (enExample)
JP2018135343A5 (enExample)
JP2009263394A5 (enExample)
JP2013542218A5 (enExample)
JP2013510120A5 (enExample)
JP2011518833A5 (enExample)
JP2013544276A5 (enExample)
JP2012092103A5 (enExample)
JP2018533593A5 (enExample)
JP2013532687A5 (enExample)
JP2016503797A5 (enExample)
JP2013534248A5 (enExample)
JP2016515560A5 (enExample)
HRP20171028T1 (hr) Indolski i indazolski spojevi koji aktiviraju ampk
HRP20151370T1 (hr) Derivati benzotiazola kao sredstva protiv raka
JP2016510323A5 (enExample)
JP2014521744A5 (enExample)
JP2011500550A5 (enExample)
JP2011137045A5 (enExample)
JP2016531126A5 (enExample)
JP2014526554A5 (enExample)